In CommitteeFiled Feb 6, 2026
Sponsor: Celina Villanueva (D)
Latest Action
Rule 3-9(a) / Re-referred to Assignments
Apr 24, 2026
Summary
The bill changes Illinois law so that, when a pharmacy or health‑care provider dispenses or a prescriber writes a prescription for mifepristone, misoprostol, or their generic versions, the label can list the name of the practice or clinic rather than the individual’s name. This affects doctors, pharmacists, and patients who use these medications and aims to give practices more control over labeling.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 3801 changes status, plus AI-powered summaries and stage predictions.
Sign up free